Package 63323-309-20

Brand: piperacillin and tazobactam

Generic: piperacillin sodium,tazobactam sodium
NDC Package

Package Facts

Identity

Package NDC 63323-309-20
Digits Only 6332330920
Product NDC 63323-309
Description

10 VIAL in 1 BOX (63323-309-20) / 10 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2009-10-13
Brand piperacillin and tazobactam
Generic piperacillin sodium,tazobactam sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "25123257-e41e-420d-9735-74fc71840b6c", "openfda": {"unii": ["UXA545ABTT", "M98T69Q7HP"], "rxcui": ["1659131", "1659137", "1659149"], "spl_set_id": ["fc4d1e35-23eb-4654-8691-ae5bfd50a48a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 BOX (63323-309-20)  / 10 mL in 1 VIAL", "package_ndc": "63323-309-20", "marketing_start_date": "20091013"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "63323-309_25123257-e41e-420d-9735-74fc71840b6c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "63323-309", "generic_name": "PIPERACILLIN SODIUM,TAZOBACTAM SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "2 g/10mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".25 g/10mL"}], "application_number": "ANDA065523", "marketing_category": "ANDA", "marketing_start_date": "20091013", "listing_expiration_date": "20261231"}